Diaceutics (FRA:7DC) Net Change in Cash : €-1.31 Mil (TTM As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Diaceutics Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Diaceutics's Net Change in Cash for the six months ended in Jun. 2024 was €0.10 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2024 was €-1.31 Mil.

Diaceutics Net Change in Cash Historical Data

The historical data trend for Diaceutics's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diaceutics Net Change in Cash Chart

Diaceutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

11.38

14.95

-6.57

0.19

-3.68

Diaceutics Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Net Change in Cash	Get a 7-Day Free Trial										0.83	-0.63	-2.29	-1.41	0.10

Diaceutics Net Change in Cash Calculation

Diaceutics's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	1.522	+	-4.886	+	-0.277	+	-0.043
	=	-3.68

Diaceutics's Net Change in Cash for the quarter that ended in Jun. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 1.362 + -1.297 + 0.044 + -0.012

= 0.10

Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-1.31 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diaceutics Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Diaceutics's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Diaceutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Diaceutics PLC (FRA:7DC) » Definitions » Net Change in Cash

Comparable Companies

LSE:OPT LSE:KOO LSE:RENX LSE:COG LSE:FDBK LSE:INHC LSE:IQAI LSE:TRLS AQSE:DXSP GEHC VEEV ASX:PME DOCS SOLV TEM HQY TSE:2413 WAY HKSE:02228 SZSE:300253

Traded in Other Exchanges

DXRX:UK

Address

Kings Hall Health and Wellbeing Park, Dataworks, First Floor, Building Two, Antrim, Belfast, GBR, BT9 6GW

Website

https://www.diaceutics.com

Diaceutics PLC is a data analytics and implementation services company that services the pharmaceutical industry. It provides the pharma and biotech companies with an end-to-end commercialization solution for the launch of precision medicine, enabled by DXRX The Diagnostic Network. DXRX is the diagnostic commercialization platform designed specifically for precision medicine, integrating multiple pipelines of real-world, real-time diagnostic testing data from a network of labs. These solutions are helping the pharma companies commercialize their precision medicines, enhance their return on investment and ultimately improve patients' lives.

Diaceutics Headlines

No Headlines